<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04789707</url>
  </required_header>
  <id_info>
    <org_study_id>RNI 2018 DUTHEIL 2</org_study_id>
    <secondary_id>2018-A02527-48</secondary_id>
    <nct_id>NCT04789707</nct_id>
  </id_info>
  <brief_title>Influence of Keratoconus on Stress at Work</brief_title>
  <acronym>KERATOSTRESS</acronym>
  <official_title>Influence of Keratoconus on Stress at Work</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Keratoconus is a progressive disorder in which central and paracentral corneal stromal&#xD;
      thinning occurs.&#xD;
&#xD;
      No studies evaluated the influence of keratoconus on stress at work, nor the influence of&#xD;
      treatments of keratoconus on stress at work, including Quality of Life at work and on&#xD;
      perception of work. Moreover, it has been shown that some pathologies had greater influence&#xD;
      in some occupations, also depending on other characteristics of individuals such as age, sex&#xD;
      or socio professional groups.&#xD;
&#xD;
      Therefore, we hypothesized that keratoconus 1) will influence stress at work including QoL at&#xD;
      work and perception of work, 2) will have a greater influence in some occupations and&#xD;
      depending on age, sex, or stage of keratoconus, 3) will induce stoppage of work and&#xD;
      occupational reclassifications.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a descriptive, prospective, observational, monocentral study. For each patient with&#xD;
      keratoconus and patient control, use of the auto questionnaire to carry out the study. we&#xD;
      only assessed data from usual routine practice.&#xD;
&#xD;
      Stress at work is measured by Job Content Questionnaire of Karasek issued during&#xD;
      consultations.&#xD;
&#xD;
      Study all workers the influence of keratoconus and its stage on:&#xD;
&#xD;
        -  consequences of keratoconus in function of visual acuity, mode of correction and staging&#xD;
           of the keratoconus.&#xD;
&#xD;
        -  Psychological consequences: Quality of life at work, Perception of work (Karasek&#xD;
           questionnaire), anxiety and depression (HAD scale)&#xD;
&#xD;
        -  Professional consequences: stoppage of work and duration and occupational&#xD;
           reclassifications&#xD;
&#xD;
        -  Characteristics of the patient: age, sex, occupation.&#xD;
&#xD;
      Measures to reduce or avoid bias:&#xD;
&#xD;
        -  Standardized, anonymous auto questionnaire&#xD;
&#xD;
        -  A large workforce: high rate of participation is expected&#xD;
&#xD;
        -  Inclusion of control group.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 4, 2021</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>stress at work</measure>
    <time_frame>day 0</time_frame>
    <description>measured by Job Content questionnaire of Karasek</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>psychological consequences</measure>
    <time_frame>Day 0</time_frame>
    <description>measured by HAD scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stoppage of work</measure>
    <time_frame>Day 0</time_frame>
    <description>professional consequences of stoppage of work : reclassifications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of stoppage of work</measure>
    <time_frame>Day 0</time_frame>
    <description>professional consequences of duration of stoppage of work : reclassifications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>characteristics of the patient</measure>
    <time_frame>day 0</time_frame>
    <description>sex, age, occupation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measure of visual acuity.</measure>
    <time_frame>Day 0</time_frame>
    <description>Consequence of keratoconous on visual acuity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mode of correction.</measure>
    <time_frame>Day 0</time_frame>
    <description>visual consequences of keratoconus on mode of correction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>staging of keratoconous</measure>
    <time_frame>Day 0</time_frame>
    <description>visual consequences of keratoconus on keratoconous stage</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">660</enrollment>
  <condition>Keratoconus in One or Two Eyes for Case</condition>
  <condition>Good Visual Acuity for Control</condition>
  <arm_group>
    <arm_group_label>KERATOCONUS group</arm_group_label>
    <description>All workers with keratoconus all stages followed at the service of ophthalmology in CHU Gabriel Montpied, Clermont-Ferrand, Auvergne.&#xD;
The investigators only assessed data from usual routine practice. Patients answer the auto questionnaire in last minutes of consultation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CONTROL group</arm_group_label>
    <description>workers with good visual acuity consulting in ophthalmology service of Clermont-Ferrand.&#xD;
The investigators only assessed data from usual routine practice. Patients answer the auto questionnaire in last minutes of consultation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>auto-questionnaire</intervention_name>
    <description>Patients answer the auto questionnaire in last minutes of consultation.</description>
    <arm_group_label>CONTROL group</arm_group_label>
    <arm_group_label>KERATOCONUS group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with keratoconus patients constituting a representative control group of workers&#xD;
        consulting in ophthalmology service of Clermont-Ferrand.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with keratoconus all stages followed at the CHU Gabriel Montpied,&#xD;
&#xD;
          -  patients constituting a representative control group of workers consulting in&#xD;
             ophthalmology service of Clermont-Ferrand.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  an other ophtalmological disease alters visual acuity.&#xD;
&#xD;
          -  minors subjects&#xD;
&#xD;
          -  inability to provide informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frédéric DUTHEIL</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lise Laclautre</last_name>
    <phone>334.73.754.963</phone>
    <email>promo_interne_drci@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU - Gabriel Montpied</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Frédéric DUTHEIL</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>March 3, 2021</study_first_submitted>
  <study_first_submitted_qc>March 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2021</study_first_posted>
  <last_update_submitted>May 5, 2021</last_update_submitted>
  <last_update_submitted_qc>May 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>keratoconus</keyword>
  <keyword>Karasek</keyword>
  <keyword>stress at work</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

